Skip to main content

For urgent surgical problems, please contact the nearest hospital emergency department.

Diabetic Foot Infection

Typical recovery: Recovery varies widely according to infection severity, tissue loss, blood supply and whether bone is involved. Mild soft-tissue infection may improve clinically within several days and is commonly treated with antibiotics for about one to two weeks. Moderate or severe infection may require hospitalisation, surgical source control and a longer recovery period. Osteomyelitis generally requires treatment over several weeks, and wound healing may take substantially longer than eradication of the infection itself.

Key points

  • Diabetic foot infection is diagnosed clinically; simply growing bacteria from a wound does not prove that the wound is infected.
  • Almost all chronic open ulcers become colonised by microorganisms, but colonisation alone is not an indication for antibiotics.
  • Do not prescribe systemic or topical antibiotics to a clinically uninfected diabetic foot ulcer merely to promote wound healing or prevent infection.
  • Classifying infection as mild, moderate or severe helps determine the need for outpatient treatment, hospitalisation, imaging, surgery and intravenous therapy.
  • Severe infection generally requires hospital-level assessment, and moderate infection may also require admission when important comorbidities or limb-threatening features are present.
  • A deep tissue sample obtained after cleansing and debridement is generally preferable to a superficial wound swab for microbiological diagnosis.
  • Osteomyelitis should be considered when an ulcer is deep, chronic, overlies a bony prominence, exposes bone or has a positive probe-to-bone test.
  • Plain radiographs remain useful initial imaging for suspected diabetic foot osteomyelitis even though early infection may not yet produce obvious X-ray changes.
  • MRI is the preferred advanced imaging test when osteomyelitis remains uncertain after clinical examination, X-rays and laboratory evaluation.
  • Bone culture provides the most specific microbiological information when osteomyelitis is suspected and obtaining a bone specimen is appropriate.
  • Antibiotics alone cannot substitute for drainage of an abscess or removal of clearly necrotic infected tissue.
  • For uncomplicated soft-tissue diabetic foot infection, guideline-supported antibiotic duration is generally 1 to 2 weeks.
  • Treatment may be extended, sometimes up to approximately 3 to 4 weeks, when infection is extensive, improving slowly or associated with severe peripheral arterial disease.
  • Failure of apparently appropriate infection treatment to resolve the problem should trigger reassessment rather than indefinite extension of the same antibiotic.
  • Diabetic foot osteomyelitis usually requires a longer treatment strategy than isolated soft-tissue infection.
  • When infected bone is not resected, guideline-supported antibiotic treatment for diabetic foot osteomyelitis is generally about 6 weeks.
  • After a minor amputation with a positive bone-margin culture, a shorter course of up to approximately 3 weeks may be appropriate.
  • Selected forefoot osteomyelitis can sometimes be treated medically without bone resection when there is no urgent need for drainage, no peripheral arterial disease and no exposed bone.
  • Peripheral arterial disease substantially worsens the prognosis of diabetic foot infection and should be actively assessed rather than judged solely by whether the foot feels warm.
  • Infection plus significant ischaemia is a limb-threatening combination and requires coordinated surgical and vascular management.
  • Offloading remains important for ulcer healing, but in severe infection or severe ischaemia the immediate priority is controlling infection and restoring adequate perfusion.
  • Negative-pressure wound therapy can be useful for selected wounds after appropriate source control, but it is not an antimicrobial treatment for diabetic foot infection itself.
  • Good glucose management, nutrition, pressure relief, smoking cessation where relevant and appropriate wound care support recovery but do not replace infection source control.

Overview

A diabetic foot infection develops when microorganisms invade the skin, soft tissues, joints or bone of the foot in a person with diabetes. Infection most often occurs through an ulcer, fissure, blister, traumatic wound or area of tissue breakdown. Because diabetic neuropathy can reduce pain sensation and peripheral arterial disease can impair healing, significant infection may progress before symptoms become dramatic. Diagnosis is primarily clinical and depends on local or systemic signs of inflammation rather than simply finding bacteria on a wound swab. The severity should be classified using a recognised system such as the IWGDF/IDSA classification because treatment ranges from outpatient oral antibiotics for selected mild infections to urgent hospitalisation, intravenous therapy, surgical drainage, debridement and vascular intervention for limb-threatening disease. A clinically uninfected diabetic foot ulcer should not receive antibiotics simply to promote healing or prevent future infection. When culture is needed, an aseptically obtained tissue specimen after cleansing and debridement is generally more useful than a superficial wound swab. Suspected osteomyelitis requires assessment of the underlying bone, initially using clinical examination, probe-to-bone testing, plain radiographs and inflammatory markers, with MRI when uncertainty remains. Successful treatment requires more than antibiotics: drainage of pus, removal of non-viable tissue, assessment of perfusion, appropriate offloading, glycaemic management and wound care are all important. When infection coexists with significant peripheral arterial disease or gangrene, surgical and vascular assessment should occur urgently because source control and restoration of blood flow may both be necessary to save the limb.

Signs & symptoms

  • Increasing redness, warmth or swelling around a diabetic foot ulcer or wound.
  • Pain or tenderness, although pain may be absent or reduced because of diabetic neuropathy.
  • Purulent or pus-like discharge from a wound.
  • Increasing wound drainage or change in the character of discharge.
  • New foul odour associated with other clinical evidence of infection.
  • Spreading cellulitis around an ulcer.
  • Soft-tissue swelling, fluctuance or features suggesting a deep abscess.
  • Dark, necrotic or gangrenous tissue.
  • Exposure or suspicion of involvement of tendon, joint or bone.
  • A wound that deteriorates rapidly despite appropriate wound care.
  • Fever, chills, tachycardia, low blood pressure, confusion or systemic illness in severe infection.
  • Occasionally very little local pain despite extensive infection because of neuropathy.

How assessment and treatment are planned

  1. 1

    Assess the patient clinically for local and systemic signs of infection and classify infection severity using the IWGDF/IDSA system.

  2. 2

    Examine the entire foot, including the ulcer depth, surrounding cellulitis, tissue viability, fluctuance, crepitus, gangrene, exposed structures and possible tracking into deeper compartments.

  3. 3

    Assess peripheral circulation because infection associated with ischaemia carries a substantially greater risk of treatment failure and amputation.

  4. 4

    Assess neuropathy, pressure points, footwear and mechanical factors contributing to the wound.

  5. 5

    Use inflammatory markers such as CRP, ESR or procalcitonin when the clinical examination is equivocal or difficult to interpret rather than using them as substitutes for clinical assessment.

  6. 6

    If microbiological diagnosis is required, cleanse and debride the wound and obtain an aseptic tissue specimen for culture rather than relying routinely on a superficial swab.

  7. 7

    For suspected osteomyelitis, use a combination of probe-to-bone testing, plain radiographs and inflammatory markers as initial investigations.

  8. 8

    Perform MRI when osteomyelitis remains uncertain despite clinical assessment, radiographs and laboratory findings.

  9. 9

    When definitive microbiology of suspected osteomyelitis is required, obtain a bone specimen for culture whenever appropriate rather than assuming that a superficial wound organism represents the bone pathogen.

  10. 10

    Start systemic antibiotics when clinical infection is present, choosing the initial regimen according to infection severity, likely pathogens, recent antibiotic exposure, previous cultures, renal function, allergies and local resistance patterns.

  11. 11

    Modify antibiotic treatment according to reliable culture and sensitivity results and clinical response.

  12. 12

    Drain pus promptly when an abscess or deep collection is present.

  13. 13

    Debride infected and non-viable tissue when necessary to achieve source control.

  14. 14

    Obtain urgent surgical assessment for severe infection or moderate infection complicated by extensive gangrene, necrotising infection, deep abscess, compartment syndrome or severe ischaemia.

  15. 15

    Consider early surgery, generally within 24 to 48 hours, together with antibiotics for selected moderate or severe infections requiring removal of infected or necrotic tissue.

  16. 16

    When infection coexists with significant peripheral arterial disease or gangrene, coordinate surgical and vascular assessment to determine the appropriate timing of drainage, debridement and revascularisation.

  17. 17

    Provide appropriate offloading and wound care after the immediate infection and ischaemia have been addressed.

  18. 18

    Reassess frequently because apparent surface improvement does not always mean that a deep infection or osteomyelitis has resolved.

Preparation

  • Bring previous wound photographs, culture reports, imaging and hospital records if available.
  • Bring a complete list of recent and current antibiotics, including dates and duration.
  • Tell the clinician about previous resistant organisms such as MRSA or Pseudomonas if these have been cultured before.
  • Bring recent diabetes records including glucose readings and HbA1c if available.
  • Mention kidney disease because renal function affects antibiotic selection and dosing.
  • Tell the team about antibiotic allergies and previous serious adverse drug reactions.
  • Report previous amputations, debridements, vascular procedures or episodes of diabetic foot osteomyelitis.
  • Bring previous vascular Doppler, angiography or revascularisation reports where relevant.
  • Tell the clinician if you smoke or have known peripheral arterial disease.
  • Avoid applying unprescribed antiseptics, antibiotic creams or home remedies immediately before assessment because these can alter the wound appearance and do not replace appropriate treatment.
  • If surgery or drainage is likely, follow fasting and medication instructions provided by the treating team.
  • Do not stop antiplatelet, anticoagulant or diabetes medications without specific instructions.

Recovery and aftercare

  • Complete the prescribed antibiotic course unless the treating clinician specifically changes or stops it.
  • Do not continue antibiotics indefinitely simply because the wound has not fully closed if clinical infection has resolved.
  • Attend wound review and debridement appointments as scheduled.
  • Follow the prescribed offloading plan and minimise mechanical pressure on the ulcerated area.
  • Check the foot daily for increasing redness, discharge, swelling, new blisters, skin breakdown or colour change.
  • Keep dressings clean and follow the wound-care plan provided by the clinical team.
  • Maintain diabetes treatment and monitor blood glucose because infection commonly worsens glycaemic control.
  • Seek early reassessment if fever, spreading cellulitis, increasing necrosis or systemic illness develops.
  • If osteomyelitis is being treated medically, attend the planned clinical, laboratory and imaging follow-up rather than judging cure from surface wound closure alone.
  • After surgery or amputation for infection, ensure the final operative findings, tissue cultures and bone-margin results are reviewed because they can affect antibiotic duration.
  • If significant peripheral arterial disease is present, follow vascular recommendations and confirm that perfusion has been adequately restored after revascularisation.
  • Once the acute infection is controlled, continue long-term ulcer prevention, footwear, pressure redistribution and regular diabetic-foot surveillance to reduce recurrence.

Risks and possible complications

  • Progression from superficial infection to deep soft-tissue infection.
  • Abscess formation.
  • Infection of tendon, joint or bone.
  • Diabetic foot osteomyelitis.
  • Necrotising soft-tissue infection.
  • Sepsis and systemic organ dysfunction.
  • Gangrene.
  • Delayed healing because of peripheral arterial disease.
  • Failure of antibiotics when infected or necrotic tissue has not been adequately drained or debrided.
  • Antibiotic adverse effects, kidney injury, drug interactions and Clostridioides difficile infection.
  • Development or selection of antimicrobial-resistant organisms after unnecessary or prolonged antibiotic use.
  • Need for repeated debridement or drainage procedures.
  • Need for revascularisation when significant limb ischaemia is present.
  • Minor amputation of one or more toes or part of the foot when tissue or bone cannot be salvaged.
  • Major lower-limb amputation in advanced uncontrolled infection, extensive tissue destruction or severe non-reconstructable ischaemia.
  • Recurrent ulceration and infection after initial healing.

When to arrange prompt medical assessment

  • New redness, warmth, swelling or discharge around a diabetic foot ulcer.
  • Increasing drainage, odour or deterioration of a previously stable wound.
  • A wound that appears deeper or begins exposing tendon, joint or bone.
  • New black, dusky or necrotic tissue.
  • Increasing foot swelling even when pain is minimal because neuropathy can mask significant infection.
  • Failure to improve after starting appropriate treatment.
  • A recurrent infection in the same location.

When to go to an emergency department now

  • Rapidly spreading redness or swelling of the foot or leg.
  • High fever, confusion, low blood pressure, marked weakness or other signs of sepsis.
  • Crepitus, rapidly progressive tissue destruction, severe systemic illness or concern for a necrotising infection.
  • A tense swollen foot with severe deep infection or concern for compartment syndrome.
  • Extensive gangrene associated with infection.
  • Infection associated with a cold, pale, cyanosed or critically ischaemic foot.
  • Sudden clinical deterioration in a patient with diabetes and an infected foot even if the wound itself looks relatively small.

Myth vs fact

Frequently asked questions

Sources

Medically reviewed by Dr. Shams Alam Mohammed Tahir, MBBS, MS (General Surgery). Last reviewed 2026-09-18.

WhatsApp